Promis Neurosciences Inc. SEC filings PMN

Promis Neurosciences Inc. has 373 filings in SEC EDGAR's recent list, going back to Aug 29, 2006. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (results of operations). The company's fiscal year ends on December 31.

Promis Neurosciences Inc. SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Regulation FD disclosure, Other events
Jul 28, 2026 Jul 28, 2026
S-8 Employee stock plan registration May 29, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
May 20, 2026 May 20, 2026
10-Q Quarterly report May 12, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 12, 2026 May 12, 2026
ARS Annual report to shareholders Apr 9, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 9, 2026 —
DEF 14A Proxy statement Apr 9, 2026 May 20, 2026
EFFECT Filing Apr 2, 2026 —
CORRESP Letter to the SEC Mar 31, 2026 —
UPLOAD Letter from the SEC Mar 31, 2026 —
EFFECT Filing Mar 26, 2026 —
S-3 Shelf registration Mar 25, 2026 —
10-K Annual report Mar 25, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 25, 2026 Mar 25, 2026
CORRESP Letter to the SEC Mar 24, 2026 —
UPLOAD Letter from the SEC Mar 23, 2026 —
S-3 Shelf registration Mar 18, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Jan 30, 2026 Jan 29, 2026
8-K Current report
Other events
Dec 16, 2025 Dec 12, 2025
8-K Current report
Bylaw or fiscal year change, Other events
Nov 24, 2025 Nov 24, 2025
8-K Current report
Shareholder vote results
Nov 19, 2025 Nov 17, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 12, 2025 Nov 12, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 24, 2025 Oct 22, 2025
DEFA14A Additional proxy material Oct 3, 2025 —
DEF 14A Proxy statement Oct 3, 2025 Nov 17, 2025
8-K Current report
Officer or director change
Sep 30, 2025 Sep 26, 2025
PRE 14A Preliminary proxy statement Sep 23, 2025 Nov 17, 2025
EFFECT Filing Sep 10, 2025 —
CORRESP Letter to the SEC Sep 8, 2025 —
UPLOAD Letter from the SEC Sep 8, 2025 —
S-3 Shelf registration Sep 4, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Sep 3, 2025 Sep 3, 2025
EFFECT Filing Aug 22, 2025 —
CORRESP Letter to the SEC Aug 20, 2025 —
UPLOAD Letter from the SEC Aug 20, 2025 —
8-K Current report
Material agreement
Aug 19, 2025 Aug 13, 2025
S-8 Employee stock plan registration Aug 13, 2025 —
S-3 Shelf registration Aug 13, 2025 —
10-Q Quarterly report Aug 13, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 13, 2025 Aug 13, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
Jul 28, 2025 Jul 28, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
Jul 22, 2025 Jul 22, 2025
424B5 Prospectus supplement Jul 22, 2025 —
8-K Current report
Material agreement, Other events
Jul 22, 2025 Jul 21, 2025
8-K Current report
Other events
Jul 7, 2025 Jul 3, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 13, 2025 Jun 12, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 12, 2025 May 12, 2025
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 29, 2025 —
DEF 14A Proxy statement Apr 29, 2025 Jun 12, 2025
424B5 Prospectus supplement Mar 31, 2025 —
8-K Current report
Results of operations
Mar 31, 2025 Mar 31, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Regulation FD disclosure
Feb 25, 2025 Feb 25, 2025
8-K Current report
Officer or director change
Feb 19, 2025 Feb 14, 2025
8-K Current report
Regulation FD disclosure
Jan 27, 2025 Jan 27, 2025
8-K Current report
Regulation FD disclosure, Other events
Jan 10, 2025 Jan 10, 2025
8-K Current report
Listing notice
Jan 8, 2025 Jan 3, 2025
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 14, 2024 Nov 14, 2024
8-K Current report
Shareholder vote results
Oct 24, 2024 Oct 23, 2024
8-K Current report
Officer or director change
Oct 10, 2024 Oct 8, 2024
DEFA14A Additional proxy material Sep 9, 2024 —
DEF 14A Proxy statement Sep 9, 2024 Oct 23, 2024
EFFECT Filing Sep 6, 2024 —
CORRESP Letter to the SEC Sep 4, 2024 —
UPLOAD Letter from the SEC Sep 3, 2024 —
S-3 Shelf registration Aug 29, 2024 —
PRE 14A Preliminary proxy statement Aug 29, 2024 Oct 23, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Other events
Jul 29, 2024 Jul 22, 2024
8-K Current report
Material agreement, Unregistered share sale, Other events
Jul 26, 2024 Jul 26, 2024
8-K Current report
Regulation FD disclosure, Other events
Jul 26, 2024 Jul 26, 2024
8-K Current report
Listing notice
Jul 5, 2024 Jul 2, 2024
8-K Current report
Shareholder vote results
Jun 14, 2024 Jun 13, 2024
10-Q Quarterly report May 14, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 14, 2024 May 14, 2024
8-K Current report
Regulation FD disclosure, Other events
Apr 30, 2024 Apr 30, 2024
ARS Annual report to shareholders Apr 25, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 25, 2024 —
DEF 14A Proxy statement Apr 25, 2024 Jun 13, 2024
424B5 Prospectus supplement Apr 1, 2024 —
10-K Annual report Apr 1, 2024 Dec 31, 2023
8-K Current report
Results of operations
Apr 1, 2024 Apr 1, 2024
8-K Current report
Material agreement
Jan 5, 2024 Jan 5, 2024
424B5 Prospectus supplement Jan 5, 2024 —
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 3, 2024 Dec 30, 2023
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
Dec 8, 2023 Dec 4, 2023
8-K Current report
Regulation FD disclosure
Nov 20, 2023 Nov 20, 2023
8-K Current report
Results of operations
Nov 14, 2023 Nov 14, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
EFFECT Filing Sep 29, 2023 —
EFFECT Filing Sep 29, 2023 —
CORRESP Letter to the SEC Sep 27, 2023 —
CORRESP Letter to the SEC Sep 27, 2023 —
S-3/A Filing Sep 27, 2023 —
S-3/A Filing Sep 27, 2023 —
EFFECT Filing Sep 25, 2023 —
UPLOAD Letter from the SEC Sep 25, 2023 —
UPLOAD Letter from the SEC Sep 25, 2023 —
S-3 Shelf registration Sep 22, 2023 —
POS AM Filing Sep 22, 2023 —
S-3 Shelf registration Sep 22, 2023 —
424B3 Prospectus Aug 22, 2023 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Aug 22, 2023 Aug 21, 2023
424B3 Prospectus Aug 14, 2023 —
8-K Current report
Results of operations
Aug 14, 2023 Aug 14, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
424B3 Prospectus Jul 14, 2023 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Jul 14, 2023 Jul 13, 2023
424B3 Prospectus Jul 10, 2023 —
8-K Current report
Other events
Jul 10, 2023 Jul 10, 2023
424B3 Prospectus Jun 30, 2023 —
8-K Current report
Shareholder vote results
Jun 30, 2023 Jun 29, 2023
ARS Annual report to shareholders Jun 1, 2023 Dec 31, 2022
DEF 14A Proxy statement Jun 1, 2023 Jun 29, 2023
PRE 14A Preliminary proxy statement May 22, 2023 Jun 29, 2023
424B3 Prospectus May 18, 2023 —
10-Q Quarterly report May 15, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 15, 2023 May 15, 2023
424B3 Prospectus May 8, 2023 —
8-K Current report
Other events
May 8, 2023 May 8, 2023
424B3 Prospectus Apr 27, 2023 —
10-K/A Amended annual report Apr 27, 2023 Dec 31, 2022
424B3 Prospectus Apr 10, 2023 —
8-K Current report
Other events
Apr 10, 2023 Apr 10, 2023
424B3 Prospectus Apr 3, 2023 —
8-K Current report
Officer or director change
Apr 3, 2023 Mar 29, 2023
EFFECT Filing Mar 23, 2023 —
POS AM Filing Mar 17, 2023 —
8-K Current report
Results of operations
Mar 8, 2023 Mar 8, 2023
10-K Annual report Mar 8, 2023 Dec 31, 2022
424B3 Prospectus Dec 6, 2022 —
8-K Current report
Officer or director change
Nov 16, 2022 Nov 10, 2022
424B3 Prospectus Nov 14, 2022 —
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 14, 2022 Nov 14, 2022
EFFECT Filing Nov 9, 2022 —
CORRESP Letter to the SEC Nov 8, 2022 —
S-1/A Amended registration statement Nov 8, 2022 —
UPLOAD Letter from the SEC Nov 7, 2022 —
S-1/A Amended registration statement Nov 4, 2022 —
S-1 Registration statement Nov 1, 2022 —
D Filing Oct 21, 2022 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Oct 17, 2022 Oct 11, 2022
8-K Current report
Material agreement, Officer or director change, Other events
Sep 13, 2022 Sep 12, 2022
S-8 Employee stock plan registration Sep 7, 2022 —
8-K Current report
Results of operations
Aug 15, 2022 Aug 15, 2022
10-Q Quarterly report Aug 12, 2022 Jun 30, 2022
8-K Current report
Auditor change
Jul 29, 2022 Jul 27, 2022
8-K Current report
Other events
Jul 8, 2022 Jul 6, 2022
SEC STAFF LETTER Filing Jul 7, 2022 —
SEC STAFF ACTION Filing Jul 7, 2022 —
CERT Form 10 cert Jul 7, 2022 —
CORRESP Letter to the SEC Jul 6, 2022 —
CORRESP Letter to the SEC Jul 1, 2022 —
10-12B/A Filing Jul 1, 2022 —
SEC STAFF LETTER Filing Jun 30, 2022 —
UPLOAD Letter from the SEC Jun 30, 2022 —
10-12B/A Filing Jun 30, 2022 —
CORRESP Letter to the SEC Jun 22, 2022 —
10-12B Filing Jun 22, 2022 —
UPLOAD Letter from the SEC Apr 26, 2022 —
DRSLTR Filing Apr 5, 2022 —
DRS/A Filing Apr 5, 2022 —
UPLOAD Letter from the SEC Feb 28, 2022 —
DRS Filing Jan 28, 2022 —
D Filing Sep 9, 2021 —
D Filing Mar 30, 2021 —
D Filing Nov 16, 2020 —
D Filing Nov 20, 2019 —
D Filing Jan 31, 2019 —
D Filing May 3, 2018 —
D/A Filing Sep 11, 2017 —
D Filing Aug 18, 2017 —
D Filing Mar 27, 2017 —
D Filing Mar 8, 2017 —
D/A Filing Nov 22, 2016 —
D Filing Sep 22, 2016 —
D Filing Aug 24, 2016 —
D/A Filing Jun 15, 2016 —
D Filing Apr 14, 2016 —
D Filing Aug 17, 2015 —
D Filing Jul 24, 2015 —
D Filing Nov 3, 2014 —
D Filing Mar 13, 2014 —
D Filing Feb 11, 2014 —
D Filing Jan 22, 2014 —
D Filing May 2, 2013 —
D Filing Apr 11, 2013 —
D Filing Mar 5, 2013 —
D Filing May 29, 2012 —
D Filing Mar 16, 2012 —
D Filing Jan 26, 2012 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PMN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Canada (Federal Level)
Headquarters
Toronto, Ontario, Canada
SEC filer status
, Emerging growth company
SEC CIK
1374339
Former names
AMORFIX LIFE SCIENCES LTD (until Nov 3, 2014)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.